HR-482 : Still Just a Bill

Newborn Screening Saves Lives Reauthorization Act of 2021

This bill reauthorizes through FY2026 and revises several programs and activities relating to newborn screening for certain conditions and genetic, endocrine, and metabolic diseases.

Among its changes, the bill reauthorizes and makes mandatory

  • the Hunter Kelly Research Program at the National Institutes of Health, and
  • national surveillance activities conducted by the Centers for Disease Control and Prevention.

The bill also aligns statutory requirements for research on non-identified newborn blood spots with federal regulations governing research on human subjects. These blood spots are collected as part of newborn screening programs, and some states make them available for biomedical and public health research. Under current regulations, research on non-identified bio-specimens such as blood spots is not considered to be research on human subjects, to which additional protections apply.

Action Timeline

Action DateTypeTextSource
2021-06-24IntroReferralReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Senate
2021-06-23FloorPursuant to section 11 of H. Res. 486, and the motion offered by Mr. McGovern, the following bills passed under suspension of the rules: H.R. 482; H.R. 704; H.R. 961, as amended; H.R. 1314; H.R. 2571, as amended; H.R. 2679, as amended; H.R. 2694; H.R. 2922, as amended; H.R. 3182; H.R. 3239; H.R. 3241, as amended; H.R. 3723; H.R. 3752; H.R. 3841; S. 409; and S. 1340. (consideration: CR H3026-3052; text: CR H3026-3027)House floor actions
2021-06-23FloorPursuant to the provisions of H. Res. 486, proceedings on H.R. 482 are considered vacated.House floor actions
2021-06-22FloorAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.House floor actions
2021-06-22FloorDEBATE - The House proceeded with forty minutes of debate on H.R. 482.House floor actions
2021-06-22FloorConsidered under suspension of the rules. (consideration: CR H2940-2942; text: CR H2940-2941)House floor actions
2021-06-22FloorMr. Pallone moved to suspend the rules and pass the bill.House floor actions
2021-02-02CommitteeReferred to the Subcommittee on Health.House committee actions
2021-01-25IntroReferralReferred to the House Committee on Energy and Commerce.House floor actions
2021-01-25IntroReferralIntroduced in HouseLibrary of Congress

Sponsor :

Lucille Roybal-Allard [D] (CA-40)
See Cosponsors

Policy Area :

Health
See Subjects
  • Child health
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Genetics
  • Government studies and investigations
  • Health information and medical records
  • Health promotion and preventive care
  • Health technology, devices, supplies
  • Medical ethics
  • Medical research
  • Medical tests and diagnostic methods
  • State and local government operations

Related Bills

See Related Bills